John A. Spertus, MD, MPH, FACC
Photo: John Spertus



Elected 2006
John Spertus, MD, MPH, FACC, is a cardiologist and the Lauer/Missouri Endowed Chair and Tenured Professor of Medicine at the University of Missouri-Kansas City where he serves as Director of Outcomes Research at the Mid America Heart Institute. He is a graduate of UCSF Medical School and completed his internal medicine, cardiology and health services training at the University of Washington. Dr. Spertus’ research has focused upon the methodology of patient-centered outcomes assessment and the quantification of healthcare quality. He developed the Seattle Angina Questionnaire (SAQ), and the Kansas City Cardiomyopathy Questionnaire (KCCQ), which have both been translated into over 40 languages and are emerging as the gold standards for quantifying patients’ symptoms, function and quality of life in coronary artery disease and heart failure. These instruments have been successfully used as endpoints in clinical trials, as markers of healthcare quality and as tools for improving patient care. Dr. Spertus assists numerous governmental and industry trials in the design and analysis of patient-centered outcomes. Dr. Spertus has held continuous NIH support for his research since 1999 and was recently awarded an NHLBI SCCOR grant in conjunction with Washington University, to pursue a translational research program describing the etiology of disparities in outcomes among minority patients and to identify the mechanisms for diabetic patients’ adverse prognosis after an acute myocardial infarction. Dr. Spertus is extremely committed to the evaluation and improvement in the quality of cardiovascular care and in related applications of outcomes research. He has served on numerous national committees for the American College of Cardiology, American Heart Association, American Medical Association, National Quality Forum, United Healthcare and Blue Cross/Blue Shield. He has also founded the Cardiovascular Outcomes Research Consortium and CV Outcomes (; a non-profit 501(c)(3) corporation dedicated to the advancement of healthcare quality and outcomes research in cardiovascular disease.